Literature DB >> 12375297

Model misspecification sensitivity analysis in estimating causal effects of interventions with non-compliance.

Booil Jo1.   

Abstract

Randomized trials often face complications in assessing the effect of treatment because of study participants' non-compliance. If compliance type is observed in both the treatment and control conditions, the causal effect of treatment can be estimated for a targeted subpopulation of interest based on compliance type. However, in practice, compliance type is not observed completely. Given this missing compliance information, the complier average causal effect (CACE) estimation approach provides a way to estimate differential effects of treatments by imposing the exclusion restriction for non-compliers. Under the exclusion restriction, the CACE approach estimates the effect of treatment assignment for compliers, but disallows the effect of treatment assignment for non-compliers. The exclusion restriction plays a key role in separating outcome distributions based on compliance type. However, the CACE estimate can be substantially biased if the assumption is violated. This study examines the bias mechanism in the estimation of CACE when the assumption of the exclusion restriction is violated. How covariate information affects the sensitivity of the CACE estimate to violation of the exclusion restriction assumption is also examined. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2002        PMID: 12375297     DOI: 10.1002/sim.1267

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  24 in total

1.  Prevention of problem behavior through annual family check-ups in early childhood: intervention effects from home to early elementary school.

Authors:  Thomas J Dishion; Lauretta M Brennan; Daniel S Shaw; Amber D McEachern; Melvin N Wilson; Booil Jo
Journal:  J Abnorm Child Psychol       Date:  2014

2.  Longitudinal Analysis when the Experimenter does not Determine when Treatment Ends: What is Dose-Response?

Authors:  Daniel J Feaster; Frederick L Newman; Christopher Rice
Journal:  Clin Psychol Psychother       Date:  2003

3.  Cluster randomized trials with treatment noncompliance.

Authors:  Booil Jo; Tihomir Asparouhov; Bengt O Muthén; Nicholas S Ialongo; C Hendricks Brown
Journal:  Psychol Methods       Date:  2008-03

4.  Mediators, moderators, and modulators of causal effects in clinical trials--Dynamically Modified Outcomes (DYNAMO) in health-related quality of life.

Authors:  Gary W Donaldson; Yoshio Nakamura; Carol Moinpour
Journal:  Qual Life Res       Date:  2009-01-20       Impact factor: 4.147

5.  Reducing aggression and impulsivity through school-based prevention programs: a gene by intervention interaction.

Authors:  Rashelle J Musci; Catherine P Bradshaw; Brion Maher; George R Uhl; Sheppard G Kellam; Nicholas S Ialongo
Journal:  Prev Sci       Date:  2014-12

6.  The Baltimore Experience Corps Trial: Enhancing Generativity via Intergenerational Activity Engagement in Later Life.

Authors:  Tara L Gruenewald; Elizabeth K Tanner; Linda P Fried; Michelle C Carlson; Qian-Li Xue; Jeanine M Parisi; George W Rebok; Lisa M Yarnell; Teresa E Seeman
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2015-02-25       Impact factor: 4.077

7.  Randomization-Based Inference within Principal Strata.

Authors:  Tracy L Nolen; Michael G Hudgens
Journal:  J Am Stat Assoc       Date:  2011-06       Impact factor: 5.033

8.  Bayesian sequential monitoring design for two-arm randomized clinical trials with noncompliance.

Authors:  Weining Shen; Jing Ning; Ying Yuan
Journal:  Stat Med       Date:  2015-03-10       Impact factor: 2.373

Review 9.  Adaptive designs for randomized trials in public health.

Authors:  C Hendricks Brown; Thomas R Ten Have; Booil Jo; Getachew Dagne; Peter A Wyman; Bengt Muthén; Robert D Gibbons
Journal:  Annu Rev Public Health       Date:  2009       Impact factor: 21.981

10.  On the use of propensity scores in principal causal effect estimation.

Authors:  Booil Jo; Elizabeth A Stuart
Journal:  Stat Med       Date:  2009-10-15       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.